Electrophysiologic characterization of the antinociceptive actions of S18616, a novel and potent alpha2-adrenoceptor agonist, after acute and persistent pain states

Journal of Pain

Volumn 3, Issue 3, 2002, Pages 234-243

  Suzuki, Rie ^b   Green, G Mark ^b   Millan, Mark J ^c   Dickenson, Anthony H ^c  

^a INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c NONE

Author keywords

Formalin; Inflammation; Nerve injury; Neuropathic pain; Rat; Spinal cord; 2 adrenoceptors

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ATIPAMEZOLE; FORMALDEHYDE; IDAZOXAN; S 18616; UNCLASSIFIED DRUG;

AFFERENT NERVE GROUP 1; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ELECTROPHYSIOLOGY; ELECTROSTIMULATION; EVOKED RESPONSE; INFLAMMATION; MALE; MECHANICAL STIMULATION; NERVE FIBER C; NERVE LIGATION; NEUROPATHY; NOCICEPTIVE STIMULATION; NONHUMAN; PAIN; PERIPHERAL NERVE INJURY; RAT; SPINAL CORD DORSAL HORN;

EID: 0036087228     PISSN: 15265900     EISSN: None     Source Type: Journal    
DOI: 10.1054/jpai.2002.123651     Document Type: Article

References (90)

1. Dexmedetomidine, a novel α2-adrenergic agonist: A review of its pharmacodynamic characteristics
2. Sensitization of pain pathways in the spinal cord: Cellular mechanisms
3. Peripheral and spinal mechanisms of nociception
4. Expression of alpha2-adrenergic receptors in rat primary afferent neurones after peripheral nerve injury or inflammation
5. International union of pharmacology nomenclature of adrenoceptors
6. Changes in the alpha 2-adrenergic receptor subtypes gene expression in rat dorsal root ganglion in an experimental model of neuropathic pain
7. Chronic arthritis increases tyrosine hydroxylase mRNA levels in the pontine noradrenergic cell groups
8. Abnormalities of sympathetic innervation in the area of an injured peripheral nerve in a rat model of neuropathic pain
9. Spinal clonidine prolongs labor analgesia from spinal sufentanil and bupivacaine
10. Epidural clonidine used as the sole analgesic agent during and after abdominal surgery: A dose-response study
11. Electrophysiological studies on the effects of intrathecal morphine on nociceptive neurones in the rat dorsal horn
12. Intrathecal drug therapy for chronic pain
13. α2-adrenergic agonists for regional anesthesia: A clinical review of clonidine (1984-1995)
14. Epidural clonidine analgesia for intractable cancer pain
15. Intrathecal, but not intravenous, clonidine reduces experimental thermal or capsaicin-induced pain and hyperalgesia in normal volunteers
16. Moxonidine, a selective α2-adrenergic and imidazoline receptor agonist, produces spinal antinociception in mice
17. The antinociceptive effects of noradrenergic agonists on the activity of the spinal dorsal horn neurones
18. A double-blind randomised comparison of the effects of epidural clonidine, lignocaine and the combination of clonidine and lignocaine in patients with chronic pain
19. Synergistic interactions between two α2-adrenoceptor agonists, dexmedetomidine and ST-91, in two substrains of Sprague-Dawley rats
20. Alpha2-adrenoceptor antagonists enhance responses of dorsal horn neurones to formalin induced inflammation
21. Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions
22. Effects of intrathecal vs systemic clonidine in treating chronic allodynia-like response in spinally injured rats
23. α- and β-adrenoceptors: From the gene to the clinic. 1. Molecular biology and adrenoceptor subclassification
24. Microinjection of morphine in the A7 catecholamine cell group produces opposing effects on nociception that are mediated by α1- and α2-adrenoceptors
25. Assessment of the role of alpha2-adrenoceptor subtypes in the antinociceptive, sedative and hypothermic action of dexmedetomidine in transgenic mice
26. Spinal opioid analgesic effects are enhanced in a model of unilateral inflammation/hyperalgesia: Possible involvement of noradrenergic mechanisms
27. The cold plate as a test of nociceptive behaviors: Description and application to the study of chronic neuropathic and inflammatory pain models
28. Noradrenergic modulation of noxious heatevoked fos-like immunoreactivity in the dorsal horn of the rat sacral spinal cord
29. In vivo gene modification elucidates subtype-specific functions of α2-adrenergic receptors
30. Systemic clonidine differentially modulates the abnormal reactions to mechanical and thermal stimuli in rats with peripheral mononeuropathy
31. Potent antinociceptive effects of clonidine systemically administered in an experimental model of clinical pain, the arthritic rat
32. Peripheral nociceptive effects of α2 adrenergic receptor agonists in the rat
33. Is sympathetic sprouting in the dorsal root ganglia responsible for the production of neuropathic pain in a rat model?
34. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat
35. The α2A adrenoceptor and the sympathetic postganglionic neuron contribute to the development of neuropathic heat hyperalgesia in mice
36. Nociceptor modulated central sensitization causes mechanical hyperalgesia in acute chemogenic and chronic neuropathic pain
37. The effects of the alpha2-adrenergic agonist, dexmedetomidine, in the spinal nerve ligation model of neuropathic pain in rats
38. Ectopic adrenergic sensitivity in damaged peripheral nerve axons in the rat
39. The origin of brainstem noradrenergic and serotonergic projections to the spinal cord dorsal horn of the rat
40. Substitution of a mutant α2A-adrenergic receptor via "hit and run" gene targeting reveals the role of this subtype in sedative analgesic, and anesthetic-sparing responses in vivo
41. Alpha2A-is the predominant alpha2-adrenergic receptor subtype in human spinal cord
42. Analysis of drug interaction between intrathecal clonidine and MK-801 in peripheral neuropathic pain rat model
43. A comparison of intrathecally administered narcotic and nonnarcotic analgesics for experimental chronic neuropathic pain
44. Influence of an experimental peripheral mononeuropathy on the responses of medial bulboreticular neurons to noxious skin stimulation and the modulation of the responses by an alpha 2-adrenoceptor agonist in the rat
45. Influence of selective α2-adrenergic agents on mustard oil-induced central hyperalgesia in rats
46. Differential effects of neurotoxic destruction of descending noradrenergic pathways on acute and persistent nociceptive processing
47. Alpha 2-adrenergic mechanisms of analgesia: Strategies for improving their therapeutic window and identification of the novel, potent alpha 2A-adrenergic receptor agonist, S 18616
48. The induction of pain: An integrative review
49. The role of descending noradrenergic and serotoninergic pathways in the modulation of nociception: Focus on receptor multiplicity
50. Multiple alpha-2 adrenergic receptor subtypes. II. Evidence for a role of rat R alpha-2A adrenergic receptors in the control of nociception, motor behavior and hippocampal synthesis of noradrenaline
51. S18616, a highly potent, spiroimidazoline agonist at α2-adrenoceptors: I. Receptor profile, antinociceptive and hypothermic actions in comparison with dexmedetomidine and clonidine
52. S18616, a highly potent spiroimidazoline agonist at a2-adrenoceptors: II. Influence on monoaminergic transmission, motor function, and anxiety in comparison with dexmedetomidine and clonidine
53. Pro- and antinociceptive actions of serotonin (5-HT)1A agonists and antagonists in rodents: Relationship to algesiometric paradigm
54. The effects of iontophoretic clonidine on neurones in the rat superficial dorsal horn
55. Pharmacology of intrathecal adrenergic agonists: Cardiovascular and nociceptive reflexes in halothane-anesthetized rats
56. The distribution and significance of CNS adrenoceptors examined with in situ hybridization
57. Distributions for mRNA's for alpha2-adrenergic receptor subtypes in rat brain: An in situ hybridization study
58. Synergistic antinociceptive interactions of morphine and clonidine in rats with nerve-ligation injury
59. Abnormal spontaneous activity and responses to norepinephrine in dissociated dorsal root ganglion cells after chronic nerve constriction
60. Nitric oxide modulated spinal antinociceptive effect of clonidine but not that of baclofen in the formalin test in rats
61. Enhanced descending modulation of nociception in rats with persistent hindpaw inflammation
62. Multiple alpha2 adrenergic receptor subtypes. I. Comparison of [3H]RX821002-labeled rat R alpha-2A adrenergic receptors in cerebral cortex to human H alpha2A adrenergic receptor and other populations of alpha-2 adrenergic subtypes
63. Roles of monoaminergic, glycinergic and GABAergic inhibitory systems in the spinal cord in rats with peripheral mononeuropathy
64. Antinociceptive actions of nitrous oxide is mediated by stimulation of noradrenergic neurones in the brainstem and activation of α2B-adrenoceptors
65. Effectiveness of tizanidine in neuropathic pain: An open-label study
66. Effects of the I (1) imidazoline/α2-adrenergic receptor agonist moxonidine in comparison with clonidine is the formalin test in rats
67. Distribution and regulation of alpha(2)-adrenoceptors in rat dorsal root ganglia
68. α2-adrenergic receptors in human spinal cord: Specific localized expression of mRNA encoding α2-adrenergic receptor subtypes at four distinct levels
69. Enhanced alpha-2 adrenergic controls and spinal morphine potency in inflammation
70. Effects of peripheral nerve injury on alpha-2A and alpha-2C adrenergic receptor immunoreactivity in the rat spinal cord
71. Alpha 2-adrenoceptor modulation of nociception in rat spinal cord: Location, effects and interactions with morphine
72. The antinociceptive actions of dexmedetomidine on dorsal horn neuronal responses in the anaesthetized rat
73. The inhibitory effects of the A1 adenosine receptor agonist, N6-cyclopentyladenosine on the electrical and natural evoked responses of spinal dorsal horn neurones in a rat model of mononeuropathy
74. The effect of intrathecally administered imiloxan and WB4101: Possible role of alpha 2-adrenoceptor subtypes in the spinal cord
75. Relative efficacy of spinal alpha-2 agonists, dexmedetomidine, clonidine and ST-91, determined in vivo by using N-ethoxycarbonyl-2-ethoxy-1, 2-dihydroquinoline, an irreversible antagonist
76. Descending modulation from the region of the locus coeruleus on nociceptive sensitivity in a rat model of inflammatory hyperalgesia
77. Laminar-selective noradrenergic and serotoninergic modulation includes spinoparabrachial cells after inflammation
78. Peripherally administered alpha2-adrenoceptor agonist in the modulation of chronic allodynia induced by spinal nerve ligation in the rat
79. Increased norepinephrine and uric acid levels in the spinal cord of arthritic rats
80. Anatomy of noradrenergic pathways modulating pain
81. Emerging molecular approaches to pain therapy
82. The pathophysiology of chronic pain increased sensitivity to low threshold A beta-fibre inputs
83. Endogenous noradrenergic tone controls symptoms of allodynia in the spinal nerve ligation model of neuropathic pain
84. Pharmacology of spinal adrenergic systems which modulate spinal nociceptive processing
85. Reversal of nerve ligation-induced allodynia by spinal alpha-2 adrenoceptor agonists
86. Clonidine, but not morphine, delays the development of thermal hyperesthesia induced by sciatic nerve constriction injury in the rat
87. Spinal pharmacology of thermal hyperesthesia induced by incomplete ligation of sciatic nerve. I. Opioid and nonopioid receptors
88. α2-adrenoceptors modulate N-methyl-D-aspartate evoked responses of neurons in superficial and deeper dorsal horn of the medulla
89. Ethical guidelines for investigations of experimental pain in conscious animals